Taiwan FDA registration f10887d5f2e11f6320a8f457d6d80973
Baijie cancer antigen CA19-9 enzyme immunoassay group
TW: 佰杰癌抗原CA19-9酵素免疫分析組
Taiwan·Risk Class 2·BIOCHECK, INC.·Registered Dec 13, 2006 – Dec 13, 2011CancelledRegistration details
- Analysis ID
- f10887d5f2e11f6320a8f457d6d80973
- Customs Code
- DHA00601783207
Company information
- Manufacturer
- BIOCHECK, INC.
- Manufacturer Country
- United States
- Authorized Representative
- GENERAL BIOLOGICALS CORP.
Product details
- Intended Use
- It is used for the quantitative analysis of serum haze of tumor antigen CA19-9.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.6010 腫瘤相關抗原免疫試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Dec 13, 2006
- Expiry Date
- Dec 13, 2011
- Cancellation Date
- May 05, 2014
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Baijie cancer antigen CA19-9 enzyme immunoassay group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f10887d5f2e11f6320a8f457d6d80973 and manufactured by BIOCHECK, INC.. The authorized representative in Taiwan is GENERAL BIOLOGICALS CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices